Lymphadenopathy Associated With Neutralizing Anti-interferon-gamma Autoantibodies Could Have Monoclonal T-cell Proliferation Indistinguishable From Malignant Lymphoma and Treatable by Antibiotics: A Clinicopathologic Study. (August 2021)

• Record Type: Journal Article
• Authors: Yuan, Chang-Tsu; Wang, Jann-Tay; Sheng, Wang-Huei; Cheng, Pei-Yuan; Kao, Chein-Jun; Wang, Jann-Yuan; Chen, Chien-Yuan; Liau, Jau-Yu; Tsai, Jia-Huei; Lin, Yi-Jyun; Chen, Chung-Chung; Chen, Yee-Chun; Chang, Shan-Chwen; Wu, Un-In
• Is Part Of: American journal of surgical pathology. Volume 45:Number 8(2021)
• Publication Date: 2021-08
• Subjects: neutralizing anti-interferon-gamma autoantibody -- disseminated nontuberculous mycobacterial infection -- angioimmunoblastic T-cell lymphoma -- IgG4-related lymphadenopathy -- idiopathic multicentric Castleman disease; Pathology, Surgical -- Periodicals; 617.0705
• DOI: 10.1097/PAS.0000000000001731
• Languages: English
• ISSNs: 0147-5185

Abstract

Abstract : Early recognition of adult-onset immunodeficiency associated with neutralizing anti-interferon gamma autoantibodies (anti-IFNγ Abs) remains difficult, and misdiagnoses have been reported. Although febrile lymphadenopathy is among the most common initial manifestations of this disorder, no comprehensive clinicopathologic analysis of lymphadenopathy in patients with anti-IFNγ Abs has been reported. Here, we describe 26 lymph node biopsy specimens from 16 patients. All patients exhibited concurrent disseminated nontuberculous mycobacterial infections, and 31% received a tentative diagnosis of lymphoma at initial presentation. We found 3 distinct histomorphologic patterns: well-formed granuloma (46%), suppurative inflammation or loose histiocytic aggregates (31%), and lymphoproliferative disorder (LPD, 23%). The latter shared some of the features of malignant T-cell lymphoma, IgG4-related disease, and multicentric Castleman disease. Half of the specimens with LPD had monoclonal T cells, and 33.3% were indistinguishable from angioimmunoblastic T-cell lymphoma as per current diagnostic criteria. All lymphadenopathy with LPD features regressed with antibiotics without administration of cytotoxic chemotherapy or immunotherapy. The median follow-up time was 4.3 years. Our study highlights the substantial challenge of distinguishing between lymphoma and other benign lymphadenopathy in the setting of neutralizing anti-IFNγ Abs. Increased vigilance and multidisciplinary discussion among clinicians and pathologists are required to achieve the most appropriate diagnosis and management. Abstract : Supplemental Digital Content is available in the text.